In Vitro Metabolism of Donepezil in Liver Microsomes Using Non-Targeted Metabolomics

In Vitro Metabolism of Donepezil in Liver Microsomes Using Non-Targeted Metabolomics

Donepezil is a reversible acetylcholinesterase inhibitor that is currently the most commonly prescribed drug for the treatment of Alzheimer’s disease. In general, donepezil is known as a safe and well-tolerated drug, and it was not associated with liver abnormalities in several clinical trials. Howe...

Full description

Bibliographic Details
Main Authors:	Sin-Eun Kim, Hyung-Ju Seo, Yeojin Jeong, Gyung-Min Lee, Seung-Bae Ji, So-Young Park, Zhexue Wu, Sangkyu Lee, Sunghwan Kim, Kwang-Hyeon Liu
Format:	Article
Language:	English
Published:	MDPI AG 2021-06-01
Series:	Pharmaceutics
Subjects:	donepezil metabolism metabolomics molecular networking multivariate analysis
Online Access:	https://www.mdpi.com/1999-4923/13/7/936

Similar Items

Revisiting the Metabolism of Donepezil in Rats Using Non-Targeted Metabolomics and Molecular Networking
by: Eun-Ji Park, et al.
Published: (2025-01-01)

Clinical Assessment of Alzheimer’s Disease and Response to Donepezil Treatment
by: Serge Gauthier
Published: (2020-12-01)

Development of donepezil-induced hypokalemia following treatment of cognitive impairment
by: Dongryul Kim, et al.
Published: (2021-01-01)

Effects of Donepezil Treatment on Brain Metabolites, Gut Microbiota, and Gut Metabolites in an Amyloid Beta-Induced Cognitive Impairment Mouse Pilot Model
by: Jae-Kwon Jo, et al.
Published: (2022-10-01)

Therapeutic Effect of Donepezil on Neuroinflammation and Cognitive Impairment after Moderate Traumatic Brain Injury
by: Dong Hyuk Youn, et al.
Published: (2024-07-01)

Delirium Associated with Donepezil in a Patient with Alzheimer’s Disease: a Case Report
by: Kamyar Mollazadeh-Moghaddam, et al.
Published: (2013-03-01)

A Multicentre, Randomised, Open-Label, Prospective Study to Estimate the Add-On Effects Of Memantine as Ebixa® Oral Pump (Solution) on Language in Patients with Moderate to Severe Alzheimer’s Disease Already Receiving Donepezil (ROMEO-AD)
by: Hee-Jin Kim, et al.
Published: (2023-05-01)

Effects of Concentration, Temperature and Polymer Type on Drug Release from Montmorillonite-Donepezil Nanocomposites
by: Naser Tavakoli, et al.
Published: (2013-04-01)

Donepezil Treatment of Hypersomnia After COVID-19
by: Demet Aygün Üstel, et al.
Published: (2021-12-01)

Nontargeted Metabolomics by High-Resolution Mass Spectrometry to Study the In Vitro Metabolism of a Dual Inverse Agonist of Estrogen-Related Receptors β and γ, DN203368
by: Sin-Eun Kim, et al.
Published: (2021-05-01)

Clinical Observation on Basal Ganglia Aphasia after Stroke Treated by Donepezil
by: Xi CHENG, et al.
Published: (2015-12-01)

Comprehensive Investigation of Stereoselective Food Drug Interaction Potential of Resveratrol on Nine P450 and Six UGT Isoforms in Human Liver Microsomes
by: Seung-Bae Ji, et al.
Published: (2021-09-01)

Evaluation of donepezil and rivastigmine administration on the cognitive deficits induced by electroconvulsive therapy: A randomized, double-blind clinical trial
by: Masoumeh Nazarinasab, et al.
Published: (2019-11-01)

Pharmacokinetic Evaluation of a Novel Donepezil-Loaded Dissolving Microneedle Patch in Rats
by: Naveed Ur Rehman, et al.
Published: (2021-12-01)

Paternal preconception donepezil exposure enhances learning in offspring
by: Guangyuan Fan, et al.
Published: (2024-09-01)

Donepezil Treatment for Alzheimer’s Disease in Chronic Dialysis Patients
by: Konstantina G. Yiannopoulou, et al.
Published: (2019-09-01)

Gene Polymorphisms Affecting the Pharmacokinetics and Pharmacodynamics of Donepezil Efficacy
by: Jin Lu, et al.
Published: (2020-06-01)

Case report: Recovery of hallucinations and cognitive impairment after administration of donepezil in a patient with schizophrenia and carbon monoxide poisoning
by: Seon-Hwa Baek, et al.
Published: (2022-11-01)

DONEPEZIL THERAPY OF UNDIFFERENTIATED DEMENTIA IN CLINICAL PRACTICE
by: Y. V. Zhitkova, et al.
Published: (2017-12-01)

Comparative Study of Donepezil-Loaded Formulations for the Treatment of Alzheimer’s Disease by Nasal Administration
by: Lupe Carolina Espinoza, et al.
Published: (2022-11-01)

Donepezil-Induced Complex Multimodal Hallucinations: Two Cases and a Review of the Literature
by: Federico Emanuele Pozzi, et al.
Published: (2022-09-01)

Donepezil-induced bradycardia in a schizophrenic patient with comorbid neurocognitive disorder: a case report and review of the literature
by: Nkolika Odenigbo, et al.
Published: (2024-03-01)

Effects of Donepezil Hydrochloride on Neuronal Response of Pyramidal Neuron of the CA1 Hippocampus in Rat Model of Alzheimer\'s Disease
by: Azade Eskandary, et al.
Published: (2019-03-01)

Inhibitory Effects of <i>Schisandra</i> Lignans on Cytochrome P450s and Uridine 5′-Diphospho-Glucuronosyl Transferases in Human Liver Microsomes
by: Hyung-Ju Seo, et al.
Published: (2021-03-01)

Model-Based Equivalent Dose Optimization to Develop New Donepezil Patch Formulation
by: Woojin Jung, et al.
Published: (2022-01-01)

Donepezil overdose and its atypical clinical presentations: A case report
by: Mohammad Delirrad, et al.
Published: (2024-01-01)

Obsessive–compulsive disorder induced by donepezil in a patient with Alzheimer's disease
by: Kohei Echizen, et al.
Published: (2024-06-01)

Donepezil reverses buprenorphine-induced central respiratory depression in anesthetized rabbits
by: SHIGEKI SAKURABA, et al.
Published: (2009-01-01)

Effects of Rikkunshi-To, a Japanese kampo medicine, on donepezil-induced gastrointestinal side effects in mice
by: Kouichi Yamamoto, et al.
Published: (2022-10-01)

Donepezil prevents RANK-induced bone loss via inhibition of osteoclast differentiation by downregulating acetylcholinesterase
by: Tsuyoshi Sato, et al.
Published: (2015-09-01)

PLGA Microspheres with Alginate-Coated Large Pores for the Formulation of an Injectable Depot of Donepezil Hydrochloride
by: Dohyun Kim, et al.
Published: (2020-04-01)

A Network Pharmacology Based Research on the Mechanism of Donepezil in Treating Alzheimer's Disease
by: Lihua Liu, et al.
Published: (2022-04-01)

Action Myoclonus Secondary to Donepezil: Case Report and Literature Review
by: Jamir Pitton Rissardo, et al.
Published: (2023-10-01)

Evaluation of the Adverse Effects of Chronic Exposure to Donepezil (An Acetylcholinesterase Inhibitor) in Adult Zebrafish by Behavioral and Biochemical Assessments
by: Gilbert Audira, et al.
Published: (2020-09-01)

Metformin and its sulphonamide derivative simultaneously potentiateanti-cholinesterase activity of donepezil and inhibit beta-amyloid aggregation
by: Magdalena Markowicz-Piasecka, et al.
Published: (2018-01-01)

Population Pharmacokinetic Modeling and Simulation for Dose Optimization of GB-5001, a Long-Acting Intramuscular Injection of Donepezil, in Healthy Participants
by: Juyoung Khwarg, et al.
Published: (2024-08-01)

Donepezil ameliorates Aβ pathology but not tau pathology in 5xFAD mice
by: Hee-Jeong Choi, et al.
Published: (2022-07-01)

Association of CHAT Gene Polymorphism rs3793790 and rs2177370 with Donepezil Response and the Risk of Alzheimer’s Disease Continuum
by: Sun H, et al.
Published: (2024-06-01)

The Preventive Effect of Donepezil on Post-Operative Cognitive Disorder in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery
by: Mojtaba Mansouri, et al.
Published: (2017-05-01)

Gold Nanoparticles Loaded with Chitosan Encapsulate Donepezil as a Novel Nanocomposite for Alzheimer's Disease Therapy
by: Lina Mohammad Saleh Al-Sarayra, et al.
Published: (2024-04-01)